Stock 2160 MICROPORT CARDIOFLOW MEDTECH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings MicroPort CardioFlow Medtech Corporation

Equities

2160

KYG6082P1054

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
1.03 HKD +5.10% Intraday chart for MicroPort CardioFlow Medtech Corporation +11.96% -36.42%
04-16 Microport Cardioflow Inks Services Deal with Subsidiary MT
04-15 MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company appears to be poorly valued given its net asset value.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
MICROPORT CARDIOFLOW MEDTECH CORPORATION Stock MicroPort CardioFlow Medtech Corporation
-36.42% 317M -
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
C
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
B+
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2160 Stock
  4. Ratings MicroPort CardioFlow Medtech Corporation